Results 181 to 190 of about 6,491 (191)

Results of clinical surveillance during the Japanese first palivizumab season in 2002–2003

Pediatrics International, 2006
Satoshi Kusuda, Hajime Togari, Masanori Fujimura   +2 more
exaly  

Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry

Journal of Perinatology, 2008
exaly  

A review of cost–effectiveness of palivizumab for respiratory syncytial virus

Expert Review of Pharmacoeconomics and Outcomes Research, 2012
Krista L Lanctôt, Abby Li, Bosco Paes
exaly  

Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIV

Pediatrics, 1998
exaly  

Use of palivizumab with other infection control measures to control respiratory syncytial virus outbreaks in neonatal care units.

Journal of Tropical Pediatrics, 2016
Abdullah Al-Taiar, Majeda S Hammoud, Mazen Al-Essa   +2 more
exaly  

Palivizumab

2016
openaire   +1 more source

Palivizumab Prophylaxis and Recurrent Wheezing

American Journal of Respiratory and Critical Care Medicine, 2018
openaire   +2 more sources

Palivizumab prophylaxis in preterm infants

The Lancet Respiratory Medicine, 2017
openaire   +2 more sources

PALIPERIDONE PALIVIZUMAB

2014
openaire   +1 more source

RSVIG AND PALIVIZUMAB: NOT THE SAME

The Pediatric Infectious Disease Journal, 2000
openaire   +1 more source